摘要
This present study reviewed the chemical diversity of marine ascidians and their pharmacological applications,challenges and recent developments in marine drug discovery reported during 1994–2014,highlighting the structural activity of compounds produced by these specimens.Till date only 5%of living ascidian species were studied from\3000 species,this study represented from family didemnidae(32%),polyclinidae(22%),styelidae and polycitoridae(11–12%)exhibiting the highest number of promising MNPs.Close to 580 compound structures are here discussed in terms of their occurrence,structural type and reported biological activity.Anti-cancer drugs are the main area of interest in the screening of MNPs from ascidians(64%),followed by anti-malarial(6%)and remaining others.FDA approved ascidian compounds mechanism of action along with other compounds status of clinical trials(phase 1 to phase 3)are discussed here in.This review highlights recent developments in the area of natural products chemistry and biotechnological approaches are emphasized.
